Search Results - "Verkes, R.J."

Refine Results
  1. 1

    Co-morbid anxiety disorders predict early relapse after inpatient alcohol treatment by Schellekens, A.F.A, de Jong, C.A.J, Buitelaar, J.K, Verkes, R.J

    Published in European psychiatry (01-01-2015)
    “…Abstract Introduction Alcohol dependence and anxiety disorders often co-occur. Yet, the effect of co-morbid anxiety disorders on the alcohol relapse-risk after…”
    Get full text
    Journal Article
  2. 2

    Efficacy and safety of medical cannabinoids in older subjects: A systematic review by van den Elsen, G.A.H, Ahmed, A.I.A, Lammers, M, Kramers, C, Verkes, R.J, van der Marck, M.A, Rikkert, M.G.M. Olde

    Published in Ageing research reviews (01-03-2014)
    “…Highlights • Older subjects (aged =65 years) participated in 105 controlled intervention studies on medical cannabinoids. • In only 5 studies data were…”
    Get full text
    Journal Article
  3. 3

    Treatment of heroin dependence with ibogaine by Schellekens, A, Oosteren, T, Knuijver, T, verkes, R.J, Belgers, M

    Published in European psychiatry (01-03-2016)
    “…Background The use of the hallucinogen ibogaine as an anti-addiction agent has been described in several case reports, dating back to the eighties. The…”
    Get full text
    Journal Article
  4. 4

    DBH −1021C>T and COMT Val108/158Met genotype are not associated with the P300 ERP in an auditory oddball task by Spronk, D.B, Veth, C.P.M, Arns, M, Schofield, P.R, Dobson-Stone, C, Ramaekers, J.G, Franke, B, de Bruijn, E.R.A, Verkes, R.J

    Published in Clinical neurophysiology (01-05-2013)
    “…Highlights ► The results revealed that neither COMT Val108/158Met in isolation nor the interaction with the DBH −1021C>T polymorphism accounted for variation…”
    Get full text
    Journal Article
  5. 5

    Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia by van Veelen, Nicoletta M.J, Grootens, Koen. P, Peuskens, J, Sabbe, B.G.C, Salden, Miriam E, Verkes, R.J, Kahn, René S, Sitskoorn, Margriet M

    Published in Schizophrenia research (01-07-2010)
    “…Abstract Background Cognitive deficits are a core feature in schizophrenia. Cognitive deficits appear to be present at the onset of schizophrenia and persist…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Effects of allopregnanolone on sedation in men, and in women on oral contraceptives by van Broekhoven, F, Bäckström, T, van Luijtelaar, G, Buitelaar, J.K, Smits, P, Verkes, R.J

    Published in Psychoneuroendocrinology (01-06-2007)
    “…Summary Allopregnanolone is a known GABA(A) receptor agonist not previously given to men, or to women using oral contraceptives (OC). The effects of…”
    Get full text
    Journal Article
  8. 8

    Effects on cognitive functioning after olanzapine–ziprasidone crossover in recent-onset schizophrenia by Grootens, K.P, van Veelen, N.M.J, Sitskoorn, M.M, Sabbe, B.G.C, Peuskens, J, Buitelaar, J.K, Verkes, R.J, Kahn, R.S

    Published in European neuropsychopharmacology (01-12-2010)
    “…Abstract Introduction To enhance functional outcome in schizophrenia improvement of cognitive symptoms is crucial. Experimental procedures Using a…”
    Get full text
    Journal Article
  9. 9

    The role of sedation tests in identifying sedative drug effects in healthy volunteers and their power to dissociate sedative-related impairments from memory dysfunctions by Wezenberg, E., Sabbe, B.G.C., Hulstijn, W., Ruigt, G.S.F., Verkes, R.J.

    Published in Journal of psychopharmacology (Oxford) (01-08-2007)
    “…The study investigated whether four specified drugs would show similar patterns on tests considered to measure sedation. In addition, their drug-effect…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20